Eli Lilly and Company (LLY) Financials

$1,160.08

$0.08 (0.01%)

As on 02-Sep-2026 16:26EDT

Market cap

$1,109,683 Mln

Revenue (TTM)

$79,666 Mln

P/E Ratio

42.9

P/B Ratio

33.7

Div. Yield

0.5 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	79,665.80	65,179.00	45,042.70	34,124.10	28,541.40	28,318.40
Cost of Revenue	12,737.00	10,564.00	8,418.30	7,082.20	6,629.80	7,312.80
Gross Profit	66,928.80	54,615.00	36,624.40	27,041.90	21,911.60	21,005.60
Operating Expenses	31,939.40	24,919.00	19,122.70	16,254.60	13,258.30	13,072.60
Operating Profit (EBIT)	34,989.40	29,696.00	17,501.70	10,787.30	8,653.30	7,933.00
Other Income	--	--	--	--	-320.90	--
Profit before Tax	33,594.40	25,729.90	12,680.40	6,554.60	6,806.40	6,155.50
Provision for Tax	6,884.90	5,091.60	2,090.40	1,314.20	561.60	573.80
Profit after Tax (Net Income)	26,709.50	20,638.30	10,590.00	5,240.40	6,244.80	5,581.70
Minority Interest	--	--	--	--	--	--
Consolidated Profit	12,218.50	20,640.00	10,590.00	5,240.40	6,244.80	5,581.70

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	33,879.00	26,535.00	14,192.10	10,771.90	10,649.80	8,979.20
Minority Interest	--	--	--	91.80	125.60	175.60
Non-Current Liabilities	60,663.00	50,713.00	36,066.70	25,849.40	21,576.20	24,598.50
Current Liabilities	47,741.00	35,228.00	28,376.60	27,293.20	17,138.20	15,052.70
Total Liabilities	190,024.00	112,476.00	78,714.90	64,006.30	49,489.80	48,806.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	77,611.00	56,847.00	45,975.20	38,279.30	31,455.30	30,353.60
Current Assets	64,672.00	55,629.00	32,739.70	25,727.00	18,034.50	18,452.40
Total Assets	190,024.00	112,476.00	78,714.90	64,006.30	49,489.80	48,806.00
Total Debt*	54,908.00	42,503.00	33,644.20	25,225.30	16,238.60	16,884.70
Net Current Assets	16,931.00	20,401.00	4,363.10	-1,566.20	896.30	3,399.70

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	16,813.00	8,817.90	4,240.10	7,084.40	7,260.70
Cash Flow from Investing Activities	--	-10,972.00	-9,301.50	-7,152.70	-3,762.90	-2,867.50
Cash from Financing Activities	--	-2,213.00	1,230.10	3,495.60	-5,406.70	-4,131.30
Net Cash Inflow / Outflow	--	--	--	--	-1,583.90	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	29.80	22.98	11.73	5.80	6.57	5.85
Cash EPS ($)	--	25.21	13.68	7.49	8.17	7.48
Adjusted Book Value ($)	--	29.55	15.71	11.92	11.21	9.42
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	18.72	9.76	4.69	7.46	7.61
Free Cash Flow per Share ($)	--	9.99	0.46	-3.49	4.84	5.65

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	35.32	25.26	16.67	23.68	23.21
ROE (%)	88.42	101.35	84.84	48.93	63.63	76.35
ROA (%)	16.19	21.59	14.84	9.23	12.71	11.70
EBIT Margin (%)	31.17	40.46	29.88	20.63	25.01	22.94
Net Margin (%)	33.53	31.66	23.51	15.36	22.13	19.71
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	49.58	0.45	0.32	0.20	0.01	0.15
EBIT Growth (%)	39.73	95.92	91.19	-1.37	9.89	-14.42
Net Profit Growth (%)	93.55	94.88	102.08	-16.08	11.88	-9.88
EPS Growth (%)	94.62	0.96	1.02	-0.12	0.12	-0.10
Book Value Growth (%)	86.67	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	42.93	46.76	65.84	100.55	55.66	47.19
Price / Book Value	33.69	36.37	49.13	48.92	32.64	29.34
Dividend Yield (%)	0.50	--	--	--	--	--
EV/EBITDA	28.47	35.81	47.77	64.11	41.76	34.36
Close Price ($)	1,199.43	1,074.68	772.00	582.92	365.84	276.22
High Price ($)	1,238.00	1,111.99	972.53	629.97	375.25	283.90
Low Price ($)	623.78	623.78	579.05	309.20	231.87	161.78
Market Cap ($ Cr)	1,109,682.95	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	1.41	1.60	2.37	2.34	1.52	1.88
Short term debt to equity ratio	0.21	0.06	0.36	0.64	0.14	0.17
Current Ratio	1.35	1.58	1.15	0.94	1.05	1.23
Quick Ratio	1.00	1.19	0.89	0.73	0.80	0.97
Interest Coverage	35.29	33.16	17.24	14.49	21.53	19.12

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	29.47	30.92	29.47	33.22	29.99	28.70
Asset Turnover	0.48	0.68	0.63	0.60	0.58	0.59
Receivable days	--	93.67	99.79	106.47	106.77	97.10
Inventory Days	--	368.80	289.87	259.99	225.76	196.45
Payable days	--	148.80	126.42	116.80	99.20	81.85
Cash Conversion Cycle	--	313.66	263.24	249.67	233.33	211.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)